Definium Therapeutics Inc (DFTX): Next-Year EPS Estimate 27.60%
As of 2026-06-04, Definium Therapeutics Inc (DFTX) has a next-year EPS growth estimate of 27.60%.
On 2026-05-17, analyst consensus for DFTX's next-year EPS growth shifted from 26.50% to 27.60% — a positive change of 1.10 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at -11.17%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.60%
- EPS growth this year
- -11.17%
- EPS next quarter (est)
- -$0.56
- Last price
- $24.59
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 27.60% | -11.17% | -$0.56 | $24.59 |
| 2026-06-03 | 27.60% | -11.17% | -$0.56 | $23.59 |
| 2026-06-02 | 27.60% | -11.17% | -$0.56 | $22.86 |
| 2026-06-01 | 27.60% | -11.17% | -$0.56 | $24.06 |
| 2026-05-31 | 27.60% | -11.17% | -$0.56 | $24.19 |
| 2026-05-28 | 27.60% | -11.17% | -$0.56 | $23.48 |
| 2026-05-27 | 27.60% | -11.17% | -$0.56 | $23.52 |
| 2026-05-26 | 27.60% | -11.17% | -$0.56 | $22.88 |
| 2026-05-25 | 27.60% | -11.17% | -$0.56 | $22.50 |
| 2026-05-24 | 27.60% | -11.17% | -$0.56 | $22.50 |
| 2026-05-21 | 27.60% | -11.17% | -$0.56 | $22.65 |
| 2026-05-20 | 27.60% | -11.17% | -$0.56 | $20.87 |
| 2026-05-19 | 27.60% | -11.17% | -$0.56 | $20.02 |
| 2026-05-18 | 27.60% | -11.17% | -$0.56 | $20.48 |
| 2026-05-17 | 27.60% | -11.17% | -$0.56 | $20.99 |
| 2026-05-14 | 26.50% | -9.86% | -$0.56 | $21.35 |
| 2026-05-13 | 26.50% | -9.86% | -$0.56 | $22.20 |
| 2026-05-12 | 25.06% | -9.04% | -$0.56 | $21.16 |
| 2026-05-11 | 25.05% | -8.07% | -$0.55 | $21.40 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Definium Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Definium Therapeutics Inc (DFTX) has a next-year EPS growth estimate of 27.60%, based on analyst consensus.
When was the latest EPS estimate revision for DFTX?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 26.50% to 27.60%.
What sector and industry does Definium Therapeutics Inc belong to?▾
Definium Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. DFTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Definium Therapeutics Inc (DFTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports